Keynesonomics

How far can the NBI fall?

NASDAQ:NBI   NASDAQ Biotechnology
4
Well, that's the million dollar question. The multi-year move, unequivocally, has been one for the books, but propensity has shifted to the downside. Momentum name valuations are getting clipped, seemingly, on a daily basis, as investor de-risking broadens and continues heading into the psychological "sell in May" period. Included are several key support levels to watch (S-1 through S-5).

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.